Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway

Fatty acid synthase (FASN) is overexpressed in most human carcinomas, including non-small cell lung cancer (NSCLC), and contributes to poor prognosis. An increasing number of studies have highlighted the poten...

Source: Lipids in Health and Disease - May 24, 2019 Category: Lipidology Authors: Ligong Chang, Surong Fang, Yubao Chen, Zhenhua Yang, Yuan Yuan, Jing Zhang, Liang Ye and Wei Gu Tags: Research Source Type: research